On November 18, the University of Virginia (UVA) announced that it received a $3.4 million NIH grant for three artificial pancreas studies to be conducted at UVA and...

Medtronic MiniMed 530G and Enlite CGM – Opening the Door to Closing the Loop.

Dr. Damiano reveals the much anticipated data from the bionic pancreas trials at the biggest diabetes tech conference of the year.

We ask ACA expert Dr. Jack Lord all the hard questions on healthcare coverage and reimbursement.

My Diabetes Home is an online dashboard that allows patients to record, organize, and track personal diabetes information, including medications, daily blood sugars, A1c...

All you need to know about diabetic neuropathy - the facts, prevention, and treatment.

Top 10 Things I Wish My Parents Knew When I Was Diagnosed with Type 1 Diabetes.

The “Bionic Kids” put the artificial pancreas through the rigors of summer camp.

The top three things I’d like to see in 2014 – updates on CGM, mHealth, and combination therapy.

On March 25, Tandem Diabetes launched t:connect, its web-based diabetes management application (PC and Mac!) that downloads data from the t:slim insulin pump and seven...

MannKind’s inhalable ultra-rapid-acting insulin Afrezza has its day at the FDA – find out what it can do for patients and how to speak up!

The New York Times publishes a critical front page piece on type 1 diabetes costs and devices - what we wish they would have written.

Choosing an insulin pump that will best meet YOUR needs.

The technology giant, Google recently announced that it is working to develop a contact lens that could non-invasively monitor glucose levels from tears. The smart...

On February 4, Dexcom announced FDA approval of the G4 Platinum CGM for children 2-17 years old in the United States. Dexcom’s G4 Platinum was previously approved in...

In April, Asante Solutions started shipping its Snap insulin pump to users in the northeastern part of US. What’s unique about the Snap is that insulin cartridges are...

On March 4, Medtronic announced the creation of a new pilot program with Aetna to provide an insulin pump to up to 300 fully insured members with uncontrolled type 2...

On April 3, an FDA Advisory Committee voted an overwhelming 13-1 in favor of approving MannKind’s ultra-rapid-acting inhaled insulin Afrezza for type 1 diabetes. The...

In August, the FDA granted clearance for the NovoPen Echo insulin pen, which will be used with NovoLog (insulin aspart) prefilled cartridges. It is the first pen device...

On January 7, the FDA announced updated standards for the accuracy of blood glucose monitors for use in both the home and healthcare facility settings. These standards...